The assessment of cryopreservation conditions for human umbilical cord stroma-derived mesenchymal stem cells towards a potential use for stem cell banking

Current Stem Cell Research and Therapy

Volumn 8, Issue 1, 2013, Pages 60-72

  Balci, Deniz ^a   Can, Alp ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Cell bank; Cryopreservation; Human umbilical cord stroma; Mesenchymal stem cells; Slow freezing

Indexed keywords

5' NUCLEOTIDASE; ALPHA SMOOTH MUSCLE ACTIN; BETA1 INTEGRIN; CRYOPROTECTIVE AGENT; CYTOKERATIN; CYTOSKELETON PROTEIN; DIMETHYL SULFOXIDE; ENDOGLIN; ETHYLENE GLYCOL; HETASTARCH; HLA DR ANTIGEN; HUMAN SERUM ALBUMIN; SUCROSE; THY 1 ANTIGEN; TREHALOSE; VIMENTIN;

ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE PHASE; CELL ISOLATION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CHROMOSOME; COMPUTER CONTROLLED MULTISTEP SLOW FREEZING; CONTROLLED STUDY; CRYOPRESERVATION; CRYSTALLIZATION; FLOW CYTOMETRY; FREEZE THAWING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STROMA; SURVIVAL RATE; UMBILICAL CORD; UMBILICAL CORD STROMA DERIVED MESENCHYMAL STEM CELL; VITRIFICATION;

BIOLOGICAL MARKERS; BIOLOGICAL SPECIMEN BANKS; CELL ENGINEERING; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; MESENCHYMAL STROMAL CELLS; PREGNANCY; STROMAL CELLS; UMBILICAL CORD;

EID: 84879746422     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X11308010008     Document Type: Article

References (52)

1. Can A, Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 2007; 25(11): 2886-95.
2. Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 2008; 26(3): 591-9.
3. Taghizadeh RR, Cetrulo KJ, Cetrulo CL. Wharton's Jelly stem cells: future clinical applications. Placenta 2011; 32 Suppl 4: S311-5.
4. Can A, Balci D. Isolation, culture, and characterization of human umbilical cord stroma-derived mesenchymal stem cells. Methods Mol Biol 2011; 698: 51-62.
5. Fan CG, Zhang QJ, Zhou JR. Therapeutic Potentials of Mesenchymal Stem Cells Derived from Human Umbilical Cord. Stem Cell Rev 2011; 7(1): 195-207.
6. Karahuseyinoglu S, Cinar O, Kilic E, et al. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 2007; 25(2): 319-31.
7. Kocaefe C, Balci D, Hayta BB, Can A. Reprogramming of human umbilical cord stromal mesenchymal stem cells for myogenic differentiation and muscle repair. Stem Cell Rev 2010; 6(4): 512-22.
8. Mitchell KE, Weiss ML, Mitchell BM, et al. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 2003; 21(1): 50-60.
9. Weiss ML, Medicetty S, Bledsoe AR, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006; 24(3): 781-92.
10. Weiss ML, Mitchell KE, Hix JE, et al. Transplantation of porcine umbilical cord matrix cells into the rat brain. Exp Neurol 2003; 182(2): 288-99.
11. Rachakatla RS, Marini F, Weiss ML, Tamura M, Troyer D. Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Ther 2007; 14(10): 828-35.
12. Wiles MV, Taft RA. The sophisticated mouse: protecting a precious reagent. Methods Mol Biol 2010; 602: 23-36.
13. Technology SfAR. Assisted reproductive technology in the United States: 2001 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology registry. Fertility and sterility 2007; 87(6): 1253-66.
14. Garcia J. Allogeneic unrelated cord blood banking worldwide: an update. Transfus Apher Sci 2010; 42(3): 257-63.
15. Mason C, Manzotti E. Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010. Regen Med 2010; 5(3): 307-13.
16. Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371(9624): 1579-86.
17. Alencar S, Garnica M, Luiz RR, et al. Cryopreservation of peripheral blood stem cell: the influence of cell concentration on cellular and hematopoietic recovery. Transfusion 2010; 50(11): 2402-12.
18. Mazur P. Kinetics of Water Loss from Cells at Subzero Temperatures and the Likelihood of Intracellular Freezing. J Gen Physiol 1963; 47: 347-69.
19. Brockback K, Covault J, Taylor M. Cryopreservation Manual. A Guide to Crypreservation Techniques. Mariette, USA: ThermoForma Scientific, Publishing Group; 2001.
20. Pegg DE. Principles of cryopreservation. In: Day JG, Stacey G, Eds. Cryopreservation and freeze-drying protocols. 2nd Ed. New Jersey: Humana Press Inc 2007; pp. 39-74.
21. Vajta G. Vitrification of the oocytes and embryos of domestic animals. Anim Reprod Sci 2000; 60-61: 357-64.
22. Meryman HT. Cryoprotective agents. Cryobiology 1971; 8(2): 173-83.
23. Tao D, Li PH. Classification of plant cell cryoprotectants. J Theor Biol 1986; 123(3): 305-10.
24. Fong CY, Subramanian A, Biswas A, et al. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells. Reprod Biomed Online 2010; 21(3): 391-401.
25. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005; 23(2): 220-9.
26. McGrath JJ. Quantitative measurement of cell membrane transport: technology and applications. Cryobiology 1997; 34(4): 315-34.
27. Leibo SP, McGrath JJ, Cravalho EG. Microscopic observation of intracellular ice formation in unfertilized mouse ova as a function of cooling rate. Cryobiology 1978; 15(3): 257-71.
28. La Rocca G, Anzalone R, Corrao S, et al. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 2009; 131(2): 267-82.
29. Ferreira RJ, Irioda AC, Cunha RC, et al. Controversies About the Chromosomal Stability of Cultivated Mesenchymal Stem Cells: Their Clinical Use is it Safe? Curr Stem Cell Res Ther 2012; 7(5): 356-63.
30. Bochkov NP, Voronina ES, Kosyakova NV, et al. Chromosome variability of human multipotent mesenchymal stromal cells. Bull Exp Biol Med 2007; 143(1): 122-6.
31. Crespo-Diaz R, Behfar A, Butler GW, et al. Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplant 2011; 20(6): 797-811.
32. Vajta G, Nagy ZP. Are programmable freezers still needed in the embryo laboratory? Review on vitrification. Reprod Biomed Online 2006; 12(6): 779-96.
33. Neto V, Buff S, Lornage J, Bottollier B, Guerin P, Joly T. Effects of different freezing parameters on the morphology and viability of preantral follicles after cryopreservation of doe rabbit ovarian tissue. Fertil steril 2008; 89(5 Suppl): 1348-56.
34. de Lima Prata K, de Santis GC, Orellana MD, Palma PV, Brassesco MS, Covas DT. Cryopreservation of umbilical cord mesenchymal cells in xenofree conditions. Cytotherapy 2012; 14(6): 694-700.
35. Moretti P, Hatlapatka T, Marten D, et al. Mesenchymal stromal cells derived from human umbilical cord tissues: primitive cells with potential for clinical and tissue engineering applications. Adv Biochem Eng Biotechnol 2010; 123: 29-54.
36. Motta JP, Gomes BE, Bouzas LF, Paraguassu-Braga FH, Porto LC. Evaluations of bioantioxidants in cryopreservation of umbilical cord blood using natural cryoprotectants and low concentrations of dimethylsulfoxide. Cryobiology 2010; 60(3): 301-7.
37. Rodrigues JP, Paraguassu-Braga FH, Carvalho L, Abdelhay E, Bouzas LF, Porto LC. Evaluation of trehalose and sucrose as cryoprotectants for hematopoietic stem cells of umbilical cord blood. Cryobiology 2008; 56(2): 144-51.
38. McGann LE. Differing actions of penetrating and nonpenetrating cryoprotective agents. Cryobiology 1978; 15(4): 382-90.
39. Lovelock JE, Bishop MW. Prevention of freezing damage to living cells by dimethyl sulphoxide. Nature 1959; 183(4672): 1394-5.
40. Petrenko YA, Jones DR, Petrenko AY. Cryopreservation of human fetal liver hematopoietic stem/progenitor cells using sucrose as an additive to the cryoprotective medium. Cryobiology 2008; 57(3): 195-200.
41. Huang YZ, Shen JL, Gong LZ, et al. [In vitro activity of human bone marrow cells after cryopreservation in liquid nitrogen for 21-25 years.]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2010; 18(1): 224-9.
42. Horwitz EM, Gordon PL, Koo WK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 2002; 99(13): 8932-7.
43. Sundin M, Ringden O, Sundberg B, Nava S, Gotherstrom C, Le Blanc K. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 2007; 92(9): 1208-15.
44. Centeno CJ, Schultz JR, Cheever M, Freeman M, Faulkner S, Robinson B, et al. Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther 2011; 6(4): 368-78.
45. Feng X, Tian S, Sun K, et al. Effect of platelet lysate on chondrogenic differentiation of human umbilical cord derived mesenchymal stem cells in vitro. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2011; 25(10): 1250-5.
46. Xue G, He M, Zhao J, et al. Intravenous umbilical cord mesenchymal stem cell infusion for the treatment of combined malnutrition nonunion of the humerus and radial nerve injury. Regen Med 2011; 6(6): 733-41.
47. Capelli C, Gotti E, Morigi M, et al. Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate. Cytotherapy 2011; 13(7): 786-801.
48. Zeddou M, Briquet A, Relic B, et al. The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biol Int 2010; 34(7): 693-701.
49. Taylor MJ, Hunt CJ. A new preservation solution for storage of corneas at low temperatures. Current Eye Res 1985; 4(9): 963-73.
50. Taylor MJ, Campbell LH, Rutledge RN, Brockbank KG. Comparison of Unisol with Euro-Collins solution as a vehicle solution for cryoprotectants. Transplant Proc 2001; 33(1-2): 677-9.
51. Han ZC. Umbilical cord mesenchymal stem cells (UC-MSC: biology, banking and clinical applications). Bull Acad Natl Med 2009; 193(3): 545-7; discussion 7.
52. Secco M, Zucconi E, Vieira NM, et al. Mesenchymal stem cells from umbilical cord: do not discard the cord! Neuromuscul Disord 2008; 18(1): 17-8.